Mr. Steven Wang is Founder & CEO of HLC. He has over 20 years of experience in the medical industry and healthcare investment and focuses exclusively on healthcare services, medical device and pharmaceutical sectors. Before founding HLC, he was a former senior partner and investment committee member of CDH. Prior to CDH, Steven served at Avenue Capital, Lehman Brothers (London) and Becton Dickinson Group. Over the last ten years, Steven was responsible for transactions totaling more than 2 billion dollars, including mergers & acquisitions, restructuring of publicly listed companies, growth and early stage investments.
Some of Mr. Wang’s representative deals include Mindray, Wuxi, Tigermed, Phamaron, Yuwell, United Imaging, Brightgene, Sansure, Smoore, Poly Pharm, Kanghong Pharmaceutical and more.